adrenopause

a·dre·no·pause

(ă-dren'ŏ-pawz),
Decrease in function of the androgen-secreting zone of the adrenal glands with increasing age, analogous to menopause.

adrenopause

(1) Cessation of adrenal gland activity.
(2) More specifically, an age-related, partial insufficiency of the adrenal cortex characterised by its low blood levels of dehydro-epiandrosterone (DHEA) and DHEA sulfate in the presence of undiminished cortisol levels.

a·dre·no·pause

(ă-drē'nō-pawz)
Decrease in function of the suprarenal glands with increasing age, analogous to menopause.
References in periodicals archive ?
Chapters address the principles, enzymes, and pathways of human steroidogenesis; glucocorticoid action, receptors, and therapy; the secretion and action of aldosterone; adrenal insufficiency; adrenal causes of hypercortisolism; defects of adrenal steroidogenesis; adrenarche and adrenopause; adrenal gland imaging; adrenocortical carcinoma; primary mineralcorticoid excess syndromes and hypertension; mineralcorticoid deficiency; pheochromocytoma; adrenal surgery; and Cushing's syndrome.
(201-204) The sharp decline in DHEA levels is often referred to as "adrenopause," and is thought to contribute to age-related increases in atherosclerosis, cancer, and dementia.
This fall in serum DHEA/DHEAS levels with age in men and women is termed the 'adrenopause' (Hazeldine et al.
Adrenopause and dehydroepiandrosterone: pharmacological therapy versus replacement therapy.